• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2013/14药理学简明指南:酶类》

The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

作者信息

Alexander Stephen P H, Benson Helen E, Faccenda Elena, Pawson Adam J, Sharman Joanna L, Spedding Michael, Peters John A, Harmar Anthony J

机构信息

School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK.

出版信息

Br J Pharmacol. 2013 Dec;170(8):1797-867. doi: 10.1111/bph.12451.

DOI:10.1111/bph.12451
PMID:24528243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3892293/
Abstract

The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of the key properties of over 2000 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.12444/full. Enzymes are one of the seven major pharmacological targets into which the Guide is divided, with the others being G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear hormone receptors, catalytic receptors and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. A new landscape format has easy to use tables comparing related targets. It is a condensed version of material contemporary to late 2013, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org, superseding data presented in previous Guides to Receptors and Channels. It is produced in conjunction with NC-IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR-DB and the Guide to Receptors and Channels, providing a permanent, citable, point-in-time record that will survive database updates.

摘要

《2013/14药理学简明指南》简要概述了2000多种人类药物靶点的关键特性及其药理学,还提供了药物靶点及其配体的开放获取知识库链接(www.guidetopharmacology.org),该知识库提供了靶点和配体特性的更详细信息。完整内容可在http://onlinelibrary.wiley.com/doi/10.1111/bph.12444/full查阅。酶是该指南划分的七个主要药理学靶点之一,其他靶点包括G蛋白偶联受体、配体门控离子通道、离子通道、核激素受体、催化受体和转运体。书中给出了命名指导以及关于现有最佳药理学工具的总结信息,还有关键参考文献和进一步阅读建议。一种新的页面格式有便于使用的表格来比较相关靶点。它是2013年末当代资料的精简版,在网站www.guidetopharmacology.org上有更详细的呈现且不断更新,取代了之前《受体与通道指南》中的数据。它是与NC - IUPHAR联合制作的,在适当的时候提供人类药物靶点的官方IUPHAR分类和命名。它整合了之前在IUPHAR - DB和《受体与通道指南》中分别整理和展示的信息,提供了一份永久性的、可引用的、特定时间点的记录,即使数据库更新也能留存。

相似文献

1
The Concise Guide to PHARMACOLOGY 2013/14: enzymes.《2013/14药理学简明指南:酶类》
Br J Pharmacol. 2013 Dec;170(8):1797-867. doi: 10.1111/bph.12451.
2
The Concise Guide to PHARMACOLOGY 2013/14: overview.《2013/14药理学简明指南》:概述
Br J Pharmacol. 2013 Dec;170(8):1449-58. doi: 10.1111/bph.12444.
3
The Concise Guide to PHARMACOLOGY 2013/14: ion channels.《2013/14药理学简明指南:离子通道》
Br J Pharmacol. 2013 Dec;170(8):1607-51. doi: 10.1111/bph.12447.
4
The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.《2013/14 药理学简明指南:配体门控离子通道》
Br J Pharmacol. 2013 Dec;170(8):1582-606. doi: 10.1111/bph.12446.
5
The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.《2013/14药理学简明指南:催化受体》
Br J Pharmacol. 2013 Dec;170(8):1676-705. doi: 10.1111/bph.12449.
6
The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors.《2013/14药理学简明指南:核激素受体》
Br J Pharmacol. 2013 Dec;170(8):1652-75. doi: 10.1111/bph.12448.
7
The Concise Guide to PHARMACOLOGY 2013/14: transporters.《2013/14药理学简明指南:转运体》
Br J Pharmacol. 2013 Dec;170(8):1706-96. doi: 10.1111/bph.12450.
8
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.《2013/14药理学简明指南:G蛋白偶联受体》
Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445.
9
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.《2015/16药理学简明指南:酶》
Br J Pharmacol. 2015 Dec;172(24):6024-109. doi: 10.1111/bph.13354.
10
The Concise Guide to PHARMACOLOGY 2015/16: Overview.《2015/16药理学简明指南:概述》
Br J Pharmacol. 2015 Dec;172(24):5729-43. doi: 10.1111/bph.13347.

引用本文的文献

1
Neuropeptides Modulate Feeding via the Dopamine Reward Pathway.神经肽通过多巴胺奖励途径调节摄食。
Neurochem Res. 2023 Sep;48(9):2622-2643. doi: 10.1007/s11064-023-03954-4. Epub 2023 May 26.
2
Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury Regulation of the AMPK/CREB/BDNF Pathway.二甲双胍急性给药可保护免受脑缺血再灌注损伤诱导的神经元凋亡:AMPK/CREB/BDNF通路的调节
Front Pharmacol. 2022 Apr 1;13:832611. doi: 10.3389/fphar.2022.832611. eCollection 2022.
3
effects of nitrosyl hydrogen on cardiac function and sarcoplasmic reticulum calcium pump (SERCA2a) in rats with heart failure after myocardial infarction.亚硝酰氢对心肌梗死后心力衰竭大鼠心脏功能及肌浆网钙泵(SERCA2a)的影响。
Cardiovasc Diagn Ther. 2020 Dec;10(6):1795-1804. doi: 10.21037/cdt-20-201.
4
Transgelin interacts with PARP1 in human colon cancer cells.在人结肠癌细胞中,凝溶胶蛋白与聚(ADP - 核糖)聚合酶1(PARP1)相互作用。
Cancer Cell Int. 2020 Aug 3;20:366. doi: 10.1186/s12935-020-01461-y. eCollection 2020.
5
Advances in research on treatment of heart failure with nitrosyl hydrogen.硝酰化氢治疗心力衰竭研究进展。
Heart Fail Rev. 2019 Nov;24(6):941-948. doi: 10.1007/s10741-019-09800-6.
6
Allosteric Modulators of Sigma-1 Receptor: A Review.西格玛-1受体的变构调节剂:综述
Front Pharmacol. 2019 Mar 19;10:223. doi: 10.3389/fphar.2019.00223. eCollection 2019.
7
Acute interaction between oral glucose (75 g as Lucozade) and inorganic nitrate: Decreased insulin clearance, but lack of blood pressure-lowering.口服葡萄糖(75 克如卢卡泽德)与无机硝酸盐的急性相互作用:胰岛素清除率降低,但无降压作用。
Br J Clin Pharmacol. 2019 Jul;85(7):1443-1453. doi: 10.1111/bcp.13913. Epub 2019 May 9.
8
Experimental Paradigm for the Assessment of the Non-pharmacological Mechanism of Action in Medical Device Classification: The Example of Glycerine as Laxative.医疗器械分类中非药物作用机制评估的实验范式:以甘油作为泻药为例
Front Pharmacol. 2018 Dec 7;9:1410. doi: 10.3389/fphar.2018.01410. eCollection 2018.
9
The genome of tapeworm Taenia multiceps sheds light on understanding parasitic mechanism and control of coenurosis disease.多头绦虫基因组揭示了对多头蚴病的寄生机制和控制的理解。
DNA Res. 2018 Oct 1;25(5):499-510. doi: 10.1093/dnares/dsy020.
10
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.3-碘甲状腺原氨酸(T1AM)及新开发的类甲状腺原氨酸TAAR1激动剂在神经保护中的潜在作用新见解
Front Pharmacol. 2017 Dec 12;8:905. doi: 10.3389/fphar.2017.00905. eCollection 2017.

本文引用的文献

1
Ceramide synthases as potential targets for therapeutic intervention in human diseases.神经酰胺合成酶作为人类疾病治疗干预的潜在靶点。
Biochim Biophys Acta. 2014 May;1841(5):671-81. doi: 10.1016/j.bbalip.2013.08.019. Epub 2013 Sep 8.
2
The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier.脂氧合酶-肝氧素途径在哺乳动物表皮屏障中的重要性。
Biochim Biophys Acta. 2014 Mar;1841(3):401-8. doi: 10.1016/j.bbalip.2013.08.020. Epub 2013 Sep 7.
3
The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication.可成药性基因组:临床试验中药物靶点的评估表明分子类别和适应症有重大转变。
Annu Rev Pharmacol Toxicol. 2014;54:9-26. doi: 10.1146/annurev-pharmtox-011613-135943. Epub 2013 Aug 30.
4
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.靶向鞘氨醇-1-磷酸轴在癌症、炎症及其他领域的作用。
Nat Rev Drug Discov. 2013 Sep;12(9):688-702. doi: 10.1038/nrd4099. Epub 2013 Aug 19.
5
AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy.AMP 激活的蛋白激酶在杜氏肌营养不良症治疗性骨骼肌重塑中的枢纽作用。
Trends Mol Med. 2013 Oct;19(10):614-24. doi: 10.1016/j.molmed.2013.07.002. Epub 2013 Jul 25.
6
Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders.磷酸二酯酶:环核苷酸信号的调节剂和运动障碍的新型分子靶点。
Eur J Pharmacol. 2013 Aug 15;714(1-3):486-97. doi: 10.1016/j.ejphar.2013.06.038. Epub 2013 Jul 10.
7
AMP-activated protein kinase: a target for old drugs against diabetes and cancer.腺苷酸活化蛋白激酶:治疗糖尿病和癌症老药的新靶点。
Biochem Pharmacol. 2013 Aug 1;86(3):339-50. doi: 10.1016/j.bcp.2013.05.023. Epub 2013 Jun 6.
8
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders.用于中枢神经系统疾病的儿茶酚-O-甲基转移酶抑制剂的基于结构的药物设计
Br J Clin Pharmacol. 2014 Mar;77(3):410-20. doi: 10.1111/bcp.12169.
9
Protein kinase C pharmacology: refining the toolbox.蛋白激酶 C 药理学:完善工具盒。
Biochem J. 2013 Jun 1;452(2):195-209. doi: 10.1042/BJ20130220.
10
Biological nitric oxide signalling: chemistry and terminology.生物一氧化氮信号转导:化学与术语。
Br J Pharmacol. 2013 Aug;169(7):1417-29. doi: 10.1111/bph.12217.